Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Publication Date timeline is not available.
Page 1
Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 128 Results from VALOR-HCM.
Circulation. 2024 Nov 18. doi: 10.1161/CIRCULATIONAHA.124.072445. Online ahead of print.
Circulation. 2024.
PMID: 39556124
Free article.
Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 56 Results From the VALOR-HCM Randomized Clinical Trial.
Desai MY, Owens A, Wolski K, Geske JB, Saberi S, Wang A, Sherrid M, Cremer PC, Lakdawala NK, Tower-Rader A, Fermin D, Naidu SS, Smedira NG, Schaff H, McErlean E, Sewell C, Mudarris L, Gong Z, Lampl K, Sehnert AJ, Nissen SE.
Desai MY, et al. Among authors: mudarris l.
JAMA Cardiol. 2023 Oct 1;8(10):968-977. doi: 10.1001/jamacardio.2023.3342.
JAMA Cardiol. 2023.
PMID: 37639243
Free PMC article.
Clinical Trial.
Item in Clipboard
The Pharmacology, Efficacy, and Safety of Rivaroxaban in Obese Patient Populations.
Ashton V, Mudarris L, Moore KT.
Ashton V, et al. Among authors: mudarris l.
Am J Cardiovasc Drugs. 2021 May;21(3):283-297. doi: 10.1007/s40256-020-00434-w.
Am J Cardiovasc Drugs. 2021.
PMID: 32803514
Free PMC article.
Review.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.